Actively Recruiting
Safety and Effectiveness of Bambini Kids Robot-Assisted Gait Training (RAGT) in Children With Cerebral Palsy
Led by COSMO ROBOTICS CO., Ltd · Updated on 2026-04-20
30
Participants Needed
1
Research Sites
37 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Cerebral palsy (CP) is a common cause of gait impairment in children, leading to limitations in mobility and daily activities. Although conventional physical therapy is widely used, it has limitations in delivering consistent and intensive training. Robot-assisted gait training (RAGT) has emerged as a promising approach to provide repetitive, high-intensity, and task-specific training, with potential benefits in gait function and motor performance. The Bambini Kids exoskeleton is a pediatric robotic device designed to assist lower-limb movements, including hip, knee, and ankle joints, to facilitate more natural gait patterns. This study aims to evaluate the safety and clinical performance of Bambini Kids in children with cerebral palsy and to generate clinical evidence to support its use in real-world rehabilitation settings.
CONDITIONS
Official Title
Safety and Effectiveness of Bambini Kids Robot-Assisted Gait Training (RAGT) in Children With Cerebral Palsy
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patient diagnosed with Cerebral Palsy
- Age from 2 to 10 years old
- Classified as Levels II to IV according to GMFCS
- Manual Muscle Testing, MMT score of 0 to 4
- Modified Ashworth Scale, MAS score of 3 and under
- Subjects with sufficient cognitive function to comply with study procedures
- Subjects with adequate upper limb function required for device use and study procedures
- Subjects who meet the physical requirements for use of the medical device as defined by the manufacturer
You will not qualify if you...
- Subjects who do not meet the criteria of age, height, weight, body dimensions, or joint range of motion
- Subjects with skin lesions, pressure sores, infections, or other conditions at area where device touches and makes difficult to use device
- Classified as Levels V according to GMFCS
- Subjects with severe spasticity (MAS > 3), or those at risk of significant worsening of spasticity after training.
- Subjects unable to maintain an upright standing position for at least 15 minutes (e.g., due to autonomic dysreflexia or orthostatic hypotension)
- Subjects with significant cardiovascular disease or a history of myocardial infarction within the past 6 months
- Subjects with medical conditions that are contraindications for use of the medical device as defined by the manufacturer.
- Subjects for whom weight-bearing, standing, or gait training is medically contraindicated (e.g., fractures, severe osteoporosis, severe joint deformity, or joint instability)
- Subjects who have received treatments affecting muscle tone within the past 4 months, such as botulinum toxin injections or baclofen pump implantation
- Subjects who experience adverse events or undesirable side effects during the clinical investigation that make continued participation difficult
- Subjects whom the investigator judges to be unsuitable for participation or continuation in the clinical investigation.
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Asan Medical center
Songpa, Seoul, South Korea, 05505
Actively Recruiting
Research Team
S
Seung Hak Lee, Associate Professor
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here